NHSE opens EOI process for future C-19 vacs service campaigns

THIS CONTENT HAS NOW EXPIRED

NHS England (NHSE) has announced the start of a new expression of interest (EOI) process for pharmacy owners that wish to take part in future COVID-19 vaccination service campaigns between September 2024 and March 2026.

The new multi-campaign approach, will mean more pharmacies will be able to choose to participate, with options to engage now or before a confirmed campaign begins. This also removes the additional administrative burden of repeated EOIs before each campaign starts. The approach unifies the EOI process and requirements for all potential providers.

However, NHSE has confirmed, despite further counter-arguments that Community Pharmacy England have put forward, that they will maintain the fee paid for vaccinations at £7.54.

The new EOI process

NHSE has published the Enhanced service specification for the service, comprehensive guidance on the EOI process and the site sign-up process:

COVID-19 vaccination Enhanced service specification and guidance on the Community Pharmacy Expression of Interest Process

Any pharmacy owners interested in submitting an expression of interest to provide the service from their pharmacy premises should start by reviewing the content of these documents.

The EOI process is on the NHS Business Services Authority’s Manage Your Service (MYS) portal and for the Autumn/Winter 2024 COVID-19 vaccination campaign, the interim response deadline for submissions is 11.59pm on 27th June 2024.

As the EOI covers provision across multiple campaigns and the details of future campaigns have not yet been confirmed, future interim response deadlines (and any final response deadlines) will be communicated via the NHSBSA website.

Pharmacy owners should note, that there is no guarantee that there will be more than one campaign across the commissioned period due to the dependence on Joint Committee on Vaccination and Immunisation (JCVI) recommendations and government decisions.  Visit the CPE website for further information.